Apoptosis in the first trimester human placenta: The role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodelling

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 100, Issue 2, 2002, Pages 138-142

  Jerzak, Malgorzata ^a,b   Bischof, Paul ^c  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Apoptosis; Fas ligand; Natural killer cell; Placenta; T cell

Indexed keywords

FAS LIGAND; FAS RECEPTOR; RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ALLOGRAFT; APOPTOSIS; BLAST TRANSFORMATION; CELL ACTIVATION; CELL METABOLISM; DECIDUA; FIRST TRIMESTER PREGNANCY; GRAFT REJECTION; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; MOTHER FETUS RELATIONSHIP; PLACENTA; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; REVIEW; TROPHOBLAST;

EID: 0037049907     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(01)00431-6     Document Type: Review

References (56)

1. Unravelling immune privilege
2. Why the baby isn't thrown out
3. Bi-directional cytokine interactions in the maternal-foetal relationship: Is successful pregnancy a TH2 phenomenon?
4. Regulation of foetal allograft survival by a hormone-controlled Th1- and Th2-type cytokines
5. Th1-type immunity is incompatible with successful pregnancy
6. Localisation of the Th2 cytokines IL-3, IL-4, IL-10 at the foeto-maternal interface during human and murine pregnancy and lack of requirement for Fas-Fas ligand interaction for a successful allogeneic pregnancy
7. T cell awareness of paternal allo-antigens during pregnancy
8. The role of FasL-induced apoptosis in immune privilege
9. Fas and FasL in the homeostatic regulation of immune responses
10. Apoptosis. Death gets a brake
11. Cell death: The significance of apoptosis
12. bcl-2 heterodimerises in vivo with a conserved homolog, bax, that accelerates programmed cell death
13. The immunolocalisation of bcl-2 at the maternal-foetal interface in healthy and failing pregnancies
14. Fas and Fas ligand: A death factor and its receptor
15. A role for CD95 ligand in preventing graft rejection
16. Fas ligand-induced apoptosis as a mechanism of immune privilege
17. Expression of Fas ligand by human cytotrophoblast: Implications in placentation and foetal survival
18. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells
19. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus
20. Trophoblasts express Fas ligand: A proposed mechanism for immune privilege in placenta and maternal invasion
21. Apoptosis of T cells in the first trimester human decidua
22. Fas-Fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease
23. Demonstration of the expression of CD95 ligand transcript and protein in human placenta
24. Lymphoid cell apoptosis induced by trophoblastic cells: A model of active foeto-placental tolerance
25. The role of placental Fas ligand in maintaining immune privilege at maternal-foetal interfaces
26. Fas and Fas-ligand are expressed in the uteroplacental unit of first trimester pregnancy
27. Apoptotic nuclei within the uterine decidua of first trimester pregnancy arise from CD45 positive leukocytes
28. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the foetus
29. Death receptor Fas/Apo-1/CD95 expressed by human placental cytotrophoblasts does not mediate apoptosis
30. The apoptosis cascade - Morphological and immunohistochemical methods for its visualisation
31. Apoptosis cascade progresses during turnover of human trophoblast: Analysis of villous cytotrophoblast and syncytial fragments in vitro
32. Caspases and cytokines: Roles in inflammation and autoimmunity
33. To be, or not to be, that is the question. Apoptosis in human trophoblast
34. TRAIL (Apo-2L) and TRAIL receptors in human placentas: Implications for immune privilege
35. Identification and functional characterisation of DR6, a novel death domain-containing TNF receptor
36. Identification and characterisation of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase
37. Maternal-foetal tolerance is maintained despite transgene-driven trophoblast expression of MHC class I, and defects in Fas and its ligand
38. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
39. Generalised lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
40. Antiphospholipid antibodies and reproduction: The antiphospholipid antibody syndrome
41. Apoptosis by death factor
42. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
43. The receptive endometrium is characterised by apoptosis in the glands
44. Fas ligand, Fas antigen and Bcl-2 expression in human endometrium during the menstrual cycle
45. Effect of decidualisation on the expression of bax and bcl-2 in the rat uterine endometrium
46. Cytokines and the regulation of apoptosis in reproductive tissues: A review
47. Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts
48. Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts
49. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta
50. The role of Bcl-2 expression in EGF inhibition of TNF-alpha/IFN-gamma-induced villous trophoblast apoptosis
51. Apoptotic and proliferative activities in first trimester placentae
52. Biology of human trophoblast
53. Oncogene and tumour suppressor gene products during trophoblast differentiation in the first trimester
54. Inverse relationship between apoptosis and Bcl-2 expression in syncytiotrophoblast and fibrin-type fibrinoid in early gestation
55. Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester
56. Placental apoptosis in normal human pregnancy